Today, forty-five organizations sent a letter to the US Senate calling for an end to the anticompetitive abuses that block competitive market entry by generic drug makers, which work to keep drug prices higher. A copy of the letter is available here.
http://www.theamericanconsumer.org/wp-content/uploads/2018/06/Final-CREATES-Act-Letter-6.7.18.pdf